最終更新日:2022/12/24
A number of clinical applications are reviewed, i.e., mutation detection in inherited cancer syndromes based on DNA-sequencing, detection of spliceogenic variants based on RNA-sequencing, DNA-sequencing to identify risk modifiers and application for pre-implantation genetic diagnosis, cancer somatic mutation analysis, pharmacogenetics and liquid biopsy.
音声機能が動作しない場合はこちらをご確認ください
編集履歴(0)
元となった例文
A
number
of
clinical
applications
are
reviewed,
i.e.,
mutation
detection
in
inherited
cancer
syndromes
based
on
DNA-sequencing,
detection
of
spliceogenic
variants
based
on
RNA-sequencing,
DNA-sequencing
to
identify
risk
modifiers
and
application
for
pre-implantation
genetic
diagnosis,
cancer
somatic
mutation
analysis,
pharmacogenetics
and
liquid
biopsy.